reference standard raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
SR9009 is generally described as poorly soluble in water and more soluble in organic solvents such as dimethyl sulfoxide and ethanol. Stock solutions are commonly prepared in an organic solvent before dilution into an aqueous buffer or vehicle. Precipitation can occur if the organic fraction is reduced too quickly or if the final concentration exceeds the compound's solubility limit. Sonication or gentle warming may aid dissolution in some protocols, but excessive heat can promote degradation. Container material and pH can also influence observed solubility.
For long-term storage, SR9009 is typically kept as a solid at low temperature, protected from moisture and light. Desiccated conditions limit hydrolysis, while opaque containers reduce photochemical breakdown. Solutions are less stable than solids and are often stored frozen in aliquots to avoid repeated freeze-thaw cycles. Stability data are not standardized across all suppliers, so users should rely on certificate-of-analysis information when available. Degradation may appear as color change, precipitate, or decreased chromatographic purity.
Laboratory identification of SR9009 typically relies on chromatographic separation coupled to mass spectrometry, often with ultraviolet detection as a secondary check. Nuclear magnetic resonance spectroscopy can confirm molecular structure when a reference standard is available. Because many suppliers sell the compound as a research chemical, independent identity testing is important for experimental reproducibility. A single retention time is not sufficient proof of identity, especially when related compounds may be present. Purity assessments usually report a percentage based on area normalization.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
The issue of whether birds should continue to be actively collected for research has been the subject of some debate among ornithologists (examples of this can be found in the lively exchanges between Remsen and Bekoff & Elzanowski, between Vuilleumier and Donegan, and between Dubois & Nemesio and Donegan). Those opposed to collecting believe that much of current collecting is unnecessary, arguably motivated by the personal field scores of individuals or by competition between museums, rather than the result of a strict scientific rationale; that collecting, in extreme cases of species on the verge of extinction, can pose a threat to bird populations; and that in many cases in which the necessity of specimens is claimed, new technology such as digital photography and blood sample analysis of mist-netted individuals could instead be used. Finally, at a time of rampant deforestation and species extinctions, scientists and conservationists should take the lead in providing an example to local people not to kill or hunt birds. Where other techniques not involving killing of a bird are feasible, to take a specimen is viewed by some as simply unethical. Proponents of collecting counter-argue that compared to the many millions of birds killed each year by habitat destruction, domestic cats, window strikes, and tower kills, scientists collect only a few thousand birds per year worldwide and populations will quickly recover from an episode of collecting as long as their habitat remains.
== History == Mestanolone was first synthesized in 1935 along with methyltestosterone and methandriol. It was developed by Roussel in the 1950s and was introduced for medical use, under the brand names Androstalone and Ermalone, by at least 1960. It was marketed in Germany. The drug was originally thought to be a potent anabolic agent, but subsequent research showed that it actually has relatively weak anabolic effects and is mostly an androgen. Mestanolone was used as a doping agent in athletes competing in the Olympics from East Germany due to a state-sponsored doping program in the 1970s and 1980s. Its value is said to have been less as a muscle-builder and more as an androgen in the central nervous system and neuromuscular interaction, improving speed, strength, aggression, focus, endurance, and stress resilience. Today, mestanolone has mostly been discontinued in medicine, though it is still available in Japan.
In 2014, Galloway opposed Western military action against Islamic State, which he called a "death cult", and instead advocated military action from the regional powers. In 2016, he supported Russian military action against Islamic State, saying: "I support the decision of the Russian government to come to the aid of the government in Syria because whatever faults it [the Syrian government] may have, whatever crimes it has committed, they are considerably fewer than the crimes committed by IS or would be committed by IS were they to come to power".
== Ecology == Many cnidarians are limited to shallow waters because they depend on endosymbiotic algae for much of their nutrients. The life cycles of most have polyp stages, which are limited to locations that offer stable substrates. Nevertheless, major cnidarian groups contain species that have escaped these limitations. Hydrozoans have a worldwide range: some, such as Hydra, live in freshwater; Obelia appears in the coastal waters of all the oceans; and Liriope can form large shoals near the surface in mid-ocean. Among anthozoans, a few scleractinian corals, sea pens and sea fans live in deep, cold waters, and some sea anemones inhabit polar seabeds while others live near hydrothermal vents over 10 km (33,000 ft) below sea-level. Reef-building corals are limited to tropical seas between 30°N and 30°S with a maximum depth of 46 m (151 ft), temperatures between 20 and 28 °C (68 and 82 °F), high salinity, and low carbon dioxide levels. Stauromedusae, although usually classified as jellyfish, are stalked, sessile animals that live in cool to Arctic waters. Cnidarians range in size from a mere handful of cells for the parasitic myxozoans through Hydra's length of 5–20 mm (1⁄4–3⁄4 in), to the lion's mane jellyfish, which may exceed 2 m (6 ft 7 in) in diameter and 75 m (246 ft) in length. Prey of cnidarians ranges from plankton to animals several times larger than themselves. Some cnidarians are parasites, mainly on jellyfish but a few are major pests of fish. Others obtain most of their nourishment from endosymbiotic algae or dissolved nutrients.
Sources: en.wikipedia.org
In such low-temperature environments, there is potential for preserving the original hydrogen isotope signal over hundreds of millions of years. However, many rocks in geologic time have reached significant thermal maturity. Even by the onset of the oil window it appears that much of the hydrogen has exchanged. Recently, scientists have explored a silver lining: hydrogen exchange is a zero order kinetic reaction (for carbon bound hydrogen at 80–100°C, the half-times are likely 104–105 years). Applying the mathematics of rate constants would allow extrapolation to original isotopic compositions. While this solution holds promise, there is too much disagreement in the literature for robust calibrations.
At the beginning of June 1976, the King visited the United States and in his speech before Congress, of whose exact content Arias Navarro was not aware, he ratified his commitment to provide Spain with a full democracy. Juan Carlos announced the Crown's will to "ensure the access to power of the different government alternatives, according to the freely expressed wishes of the Spanish people". A month and a half earlier, Newsweek magazine had claimed that King Juan Carlos had told one of its journalists ─ which was never denied ─ that "Arias was an unmitigated disaster". Around the same time Arias Navarro had made a statement on television in which he had made harsh attacks on the democratic opposition, while his relations with the king had deteriorated to the point that Arias had confessed to one of his closest collaborators: "It happens to me like with children; I can't stand him for more than ten minutes". After commenting to Areilza "this cannot go on, at the risk of losing everything ...", Juan Carlos demanded Arias Navarro on July 1 to present his resignation, which he did immediately. A few days later, Torcuato Fernández Miranda succeeded in getting the Council of the Realm to include among the three aspirants for President of the Government the "king's candidate": Adolfo Suárez, a "blue reformist" who had not stood out too much until then. Suárez's appointment caused enormous bewilderment and disappointment among the democratic opposition and diplomatic circles, as well as in newspaper editorial offices.
=== Photo-biomodulation therapy (PBMT) mechanism === Photobiomodulation therapy (PBMT) uses low-power densities and is characterized by its non-heat producing effects, a feature previously associated only with laser light. Nowadays, low-level LED lights offer a cost-effective alternative, expanding the accessibility and application of this therapeutic approach. PBMT (low-level light) targets mitochondria and has impacts on, 1) raising ROS levels, 2) creating adenosine triphosphate (ATP); and 3) helping to turn on transcription factor. That can trigger biochemical change within the cells, involve photon emitting light absorbed by the photoreceptor and cascade reaction. When exposed to LED light, the cytochrome c oxidase (CCO) inside the electron transport chain (ETC) of mitochondria is targeted. Its two heme and two copper subunits are oxidized or reduced, enabling it to absorb light at various wavelengths. CCO is the main target of near-infrared and red(650-1000 nm) wavelengths. Cytochrome c oxidase (CCO) is a key protein in the Electron Transport Chain, responsible for transferring electrons to the final oxygen acceptor. This action helps build a substantial proton gradient across the inter-membrane space of mitochondria; a process critical for the synthesis of ATP (Adenosine Triphosphate). The increased production of ATP because of this activity. CCO is also a photoreceptor, the photon absorption of CCO can lead to enhanced enzyme activity, increased oxygen consumption and usage of ATP production and the release of NO (nitric oxide).
== Further reading == Bran the Blessed in Arthurian Romance by Helaine Newstead. Columbia University Press 1939. The Grail: From Celtic Myth to Christian Symbol by Roger Sherman Loomis. ISBN 0-691-02075-2. From Ritual to Romance by Jessie Weston.
=== June === 1 June House prices in the UK are reported to have fallen by 3.4% in the year to May, the biggest decline since July 2009. The average property price is now estimated at £260,736. A ban on e-scooters carried on Southeastern, Southern, Thameslink and Gatwick Express trains comes into force, due to concerns over fire risk. 2 June – A visibly emotional Phillip Schofield gives an interview with the BBC's Amol Rajan, in which he apologises and says his "career is over" following the affair with a young male colleague. 3 June Train strikes staged by the ASLEF union cause disruption to the 2023 FA Cup final and a Beyoncé Knowles concert. In the FA Cup Final, the first in the 152-year history of the competition to feature a Manchester derby, Manchester City defeat rivals Manchester United 2–1 to win their seventh FA Cup trophy. A man is arrested at the FA Cup final after being pictured wearing a Manchester United shirt with the number 97 and the slogan "not enough", believed to be a reference to the Hillsborough disaster. The 33-year-old male is subsequently charged with displaying threatening or abusive writing likely to cause harassment, alarm or distress. A protestor is detained by police after attempting to disrupt the 2023 Epsom Derby by trespassing on the track. 6 June Record high numbers of gonorrhoea and syphilis infections are reported, following a dip during previous years.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
Liquid chromatography with mass spectrometry is a common approach. Ultraviolet detection and nuclear magnetic resonance can support identification when suitable standards are available.